TMCI — TREACE MEDICAL CONCEPTS, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1630627 ·
Last close
$4.44
Market Cap
$288.75M
52W High
$5.44
52W Low
$1.17
ADV30
293,235
Next earnings
2026-11-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 48,253,000 | 38,350,000 | -11,532,000 | -12,566,000 | 179,300,000 | 7,760,000 | 117,654,000 |
| Jun 2026 | 45,376,000 | 35,607,000 | -14,958,000 | -15,873,000 | 181,055,000 | 12,610,000 | 113,318,000 |
| Mar 2026 | 47,198,000 | 37,407,000 | -17,167,000 | -17,961,000 | 184,102,000 | 9,544,000 | 106,911,000 |
| Dec 2025 | 62,519,000 | 50,401,000 | -5,922,000 | -9,394,000 | 190,581,000 | 10,708,000 | 103,249,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-14,576,000
Investing CF
$17,654,000
Financing CF
$1,480,000
CapEx
$-10,470,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.93
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-282,826,000
Inventory
$39,542,000
Receivables
$28,732,000
ST Investments
$33,009,000
EBIT TTM
$-53,696,000
Pretax Income TTM
$-59,516,000
Interest Exp TTM
$5,820,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$205,307,008
EBITDA
$-46,350,000
Free Cash Flow
$-6,252,375
Enterprise Value
$289,520,256
Total Cash
$45,619,000
Total Debt
$73,050,000
Shares Out
65,034,552
Trailing EPS
$-0.85
Book Value
$1.04
ROE
-72.0%
ROA
-17.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 212,690,000 | -54,154,000 | -59,002,000 | 190,581,000 | 103,249,000 | 87,332,000 | -15,970,000 |
| Dec 2024 | 209,357,000 | -55,688,000 | -55,743,000 | 217,094,000 | 104,202,000 | 112,892,000 | -37,167,000 |
| Dec 2023 | 187,118,000 | -51,428,000 | -49,527,000 | 251,907,000 | 113,969,000 | 137,938,000 | -34,575,000 |
| Dec 2022 | 141,838,000 | -34,844,000 | -42,815,000 | 159,024,000 | 98,495,000 | 60,529,000 | -30,648,000 |
TTM Snapshot
Revenues TTM
$205,307,000
NetIncome TTM
$-59,516,000
OpCashFlow TTM
—
Assets (Latest)
$181,055,000
Forward EPS
$-0.85
Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $4.53 · call volume: 4 · put volume: 1,526
Expected Move to 2027-03-19:
±$2.29
(50.55%) —
implied range
$2.24 –
$6.82
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NPCE | NeuroPace Inc | $282.50M | $8.20 | — |
| INFU | InfuSystem Holdings, Inc | $296.30M | $14.79 | — |
| SMTI | Sanara MedTech Inc. | $300.55M | $32.73 | — |
| OFIX | Orthofix Medical Inc. | $271.87M | $6.67 | — |
| SSII | SS Innovations International, Inc. | $266.51M | $1.33 | — |
News headlines (Yahoo Finance, 1h cache)
Treace Medical Concepts Inc (TMCI) Q3 2026 Earnings Call Highlights: Revenue Slips 4% but ...
2026-11-06 23:13 · Yahoo
What Treace Medical Concepts (TMCI) Said on Its Q3 Earnings Call
2026-11-06 21:14 · Yahoo
Treace Medical Concepts, Inc. Q3 2026 Earnings Call Summary
2026-11-06 18:24 · Yahoo
Treace Medical (TMCI) Q3 2026 Earnings Call Transcript
2026-11-06 17:43 · Yahoo
Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates
2026-11-06 12:25 · Yahoo
Treace Medical Concepts: Q3 Earnings Snapshot
2026-11-06 12:21 · Yahoo
Treace Medical Concepts Reports Third Quarter 2026 Financial Results
2026-11-06 12:05 · Yahoo
Treace Announces First Surgical Cases with the Tailorplasty™ MIS Tailor’s Bunion Correction System
2026-11-06 12:04 · Yahoo
Treace to Present at the Stifel 2026 Healthcare Conference
2026-11-03 21:05 · Yahoo
Treace to Report Third Quarter 2026 Financial Results on November 6, 2026
2026-10-23 11:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.